BSE/TSE risks associated with active pharmaceutical ingredients and starting materials: the situation in Europe and the global implications for healthcare …

B Matthews - PDA Journal of Pharmaceutical Science and …, 2001 - journal.pda.org
BSE/TSE Risks Associated with Active Pharmaceutical Ingredients and Starting Materials: The
Situation in Europe and the Global Implications for Healthcare Manufacturers | PDA Journal of …

Use of substances of animal origin in pharmaceutics and compliance with the TSE-risk guideline–a market survey

CN Berger, P Le Donne, H Windemann - Biologicals, 2005 - Elsevier
The risk of infection with transmissible spongiform encephalopathy (TSE) from the use of
animal-derived substances in drug manufacturing was assessed [Swissmedic. TSE …

[PDF][PDF] Scientific advice in support to risk management with regard to BSE.

P Vossen - Presented at the International Symposium on BSE, 2001 - researchgate.net
The core of the scientific advisory system of the European Com-mission (EC) comprises nine
scientific committees including a Scientific Steering Committee (SSC) which cover the …

Recent regulatory trends in pharmaceutical manufacturing and their impact on the industry

D Tabersky, M Woelfle, JA Ruess, S Brem… - Chimia, 2018 - chimia.ch
The pharmaceutical industry is one of the most regulated industries in Switzerland. Though
the concept of good manufacturing practises (GMP) was implemented for chemical …

Risk assessment of food contact materials II

E Galbiati, T Tietz, S Zellmer, S Merkel - EFSA journal, 2022 - Wiley Online Library
Food contact materials (FCMs) are materials and articles intended to be placed in direct or
indirect contact with foodstuffs, or which can reasonably be expected to come into contact …

[HTML][HTML] EMA guideline on setting health-based exposure limits

A Teasdale, L Rutter, C Callis, B Naumann… - Pharmaceutical …, 2015 - pharmtech.com
An industry workgroup comprised of toxicologists and manufacturing equipment cleaning
subject matter experts was formed to examine the European Medicines Agency (EMA) …

Pharmaceuticals and personal care products: risks, challenges, and solutions

Z Hoyett - Risk Assess, 2018 - books.google.com
Pharmaceuticals and personal care products (PPCPs) encompass a large class of chemical
contaminants that can originate from human usage and excretions and veterinary …

A new method for risk assessment of pharmaceutical excipients

YV Pidpruzhnykov, OA Ruban, TY Kolisnyk - 2018 - dspace.nuph.edu.ua
According to the modern requirements of the European Union's Good Manufacturing
Practice for Medicinal Products, a manufacturing authorization holder should guarantee the …

A safety risk-based extractables and/or leachables qualification strategy for packaged drug products

D Jenke - PDA Journal of Pharmaceutical Science and …, 2021 - journal.pda.org
During storage and distribution of a packaged drug product, chemical substances present in
or on the packaging may leach into the drug product, potentially adversely affecting the drug …

TSE risk assessment for starting materials used during, or in the manufacture of vaccines for human use--a consultant's view of the commercial approach.

R Bradley - Developments in biologicals, 2006 - europepmc.org
Vaccination is an essential tool to protect humans from many infectious diseases. Materials
derived from bovine tissues are used in, or during the manufacture of, most vaccines …